loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2002_050___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    GSK

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 GlaxoSmithKline Research & Development Limited Brentford GB (1)

    filter

    01 Cefuroxime axetil (1)

    filter

    01 United Kingdom (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    GlaxoSmithKline Research & Developm...

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Cefuroxime axetil

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2002-050 - Rev 02
    Withdrawn by Holder
    Chemical
    2013-07-02
    2019-10-24
    1300
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2002-050 - Rev 02 of Glaxosmithkline Research & Development Limited Brentford Gb

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2002-050 - Rev 02 of Glaxosmithkline Research & Development Limited Brentford Gb 1

    20

    Glaxosmithkline Research & Development Limited Brentford Gb, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their significant offerings is Cefuroxime axetil, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2002-050 - Rev 02

    This Chemical Type CEP, issued on July 02, 2013, remains in force until October 24, 2019, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1300 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY